The Life Sciences Tools and Services industry on FinBizNet covers 27 listed companies, with broker-view summaries, sub-industry segmentation, latest quarterly results and peer comparisons for each constituent.
| Listed companies | 27 |
|---|---|
| Combined market cap | ₹4,52,241 Cr |
| Median P/E (profitable companies) | 41.2 |
| Median return on equity | 8.1% |
| Companies with latest quarterly results | 22 of 27 |
| Company | Market Cap | P/E | ROE | Quarterly Revenue | Quarterly Net Profit | Quarter |
|---|---|---|---|---|---|---|
| Divis Laboratories Limited | ₹2,40,249 Cr | 93.6 | 16.2% | ₹3,080 Cr | ₹902 Cr | Q1 FY27 |
| Anthem Biosciences Limited | ₹46,309 Cr | 78.8 | 19.4% | ₹418 Cr | ₹120 Cr | Q1 FY27 |
| Sai Life Sciences Limited | ₹30,701 Cr | 88.0 | 15.1% | ₹554 Cr | ₹73 Cr | Q1 FY27 |
| Cohance Lifesciences Ltd | ₹17,735 Cr | 99.0 | 5.1% | ₹422 Cr | ₹-45 Cr | Q1 FY27 |
| Onesource Specialty Pharma Limited | ₹16,023 Cr | — | -1.3% | ₹516 Cr | ₹57 Cr | Q2 FY27 |
| Jubilant Pharmova Ltd | ₹14,860 Cr | 37.4 | 6.0% | ₹2,229 Cr | ₹56 Cr | Q1 FY27 |
| Indegene Ltd | ₹14,496 Cr | 36.2 | 13.9% | ₹1,063 Cr | ₹116 Cr | Q1 FY27 |
| Syngene International Ltd. | ₹14,326 Cr | 45.7 | 6.6% | ₹736 Cr | ₹-9 Cr | Q1 FY27 |
| Concord Biotech Ltd | ₹13,717 Cr | 52.6 | 13.5% | ₹257 Cr | ₹56 Cr | Q1 FY27 |
| Akums Drugs and Pharmaceuticals Limited | ₹10,512 Cr | 41.2 | 8.0% | ₹1,167 Cr | ₹101 Cr | Q1 FY27 |
| Blue Jet Healthcare Ltd | ₹9,191 Cr | 34.0 | 19.9% | ₹293 Cr | ₹78 Cr | Q1 FY27 |
| Suven Life Sciences Ltd. | ₹7,410 Cr | — | -78.8% | ₹4 Cr | ₹-128 Cr | Q1 FY27 |
| INNOVA CAPTAB LIMITED | ₹5,712 Cr | 40.5 | 14.0% | ₹471 Cr | ₹44 Cr | Q1 FY27 |
| Vimta Labs Ltd | ₹2,201 Cr | 28.6 | 18.6% | ₹109 Cr | ₹21 Cr | Q1 FY27 |
| Dishman Carbogen Amcis Ltd | ₹2,177 Cr | 22.3 | 1.6% | ₹678 Cr | ₹-58 Cr | Q1 FY27 |
| Windlas Biotech Ltd | ₹1,821 Cr | 28.3 | 12.2% | ₹248 Cr | ₹18 Cr | Q1 FY27 |
| Tarsons Products Limited | ₹1,587 Cr | 110.9 | 2.3% | ₹110 Cr | ₹-1 Cr | Q1 FY27 |
| Borosil Scientific Limited | ₹939 Cr | 27.1 | 8.2% | ₹107 Cr | ₹4 Cr | Q1 FY27 |
| Influx Healthtech Limited | ₹596 Cr | 27.5 | 20.4% | — | — | — |
| Fabtech Technologies Limited | ₹543 Cr | 12.2 | 9.1% | ₹75 Cr | ₹4 Cr | Q1 FY27 |
| Rays of Belief Limited | ₹528 Cr | 78.0 | — | ₹25 Cr | ₹3 Cr | Q1 FY27 |
| Bilcare Ltd. | ₹201 Cr | 112.0 | -5.2% | — | — | — |
| Brooks Laboratories Ltd. | ₹170 Cr | 6.9 | 22.3% | ₹23 Cr | ₹1 Cr | Q1 FY27 |
| Jeevan Scientific Technology Ltd | ₹165 Cr | 121.0 | 1.7% | — | — | — |
| Vivo Bio Tech Ltd. | ₹28 Cr | — | -2.0% | ₹14 Cr | ₹0 Cr | Q1 FY27 |
| Dr. Habeebbullal Life Sciences Ltd | ₹28 Cr | — | -68.8% | — | — | — |
| Vanta Bioscience Ltd | ₹15 Cr | 136.0 | 0.9% | — | — | — |
Market data from the FinBizNet stock universe; quarterly figures in ₹ crore, parsed from each company's exchange filing (XBRL).
FinBizNet tracks 27 listed companies in the Life Sciences Tools and Services industry, including Divis Laboratories Limited, Anthem Biosciences Limited, Sai Life Sciences Limited, Cohance Lifesciences Ltd, Onesource Specialty Pharma Limited, Jubilant Pharmova Ltd, Indegene Ltd, Syngene International Ltd., among others.
By market capitalisation, the largest Life Sciences Tools and Services companies are Divis Laboratories Limited (₹2,40,249 Cr), Anthem Biosciences Limited (₹46,309 Cr), Sai Life Sciences Limited (₹30,701 Cr), Cohance Lifesciences Ltd (₹17,735 Cr), Onesource Specialty Pharma Limited (₹16,023 Cr).
The 27 Life Sciences Tools and Services companies tracked on FinBizNet have a combined market capitalisation of about ₹4,52,241 Cr.
The median price-to-earnings ratio across 23 profitable Life Sciences Tools and Services companies is 41.2, and the median return on equity across the industry is 8.1%. Medians are shown for context only.
FinBizNet aggregates broker research, sub-industry breakdowns, quarterly results and peer-stock comparisons across the Life Sciences Tools and Services industry.